(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -7.96%37B | -8.60%24.63B | -9.52%16.63B | 7.92%7.49B | 4.81%40.2B | 6.36%26.94B | 2.90%18.38B | 5.62%6.94B | -4.40%38.36B | 5.89%25.33B |
Special items of operating revenue | 419.25%85.19M | --57.51M | --33.22M | --12.48M | --16.41M | ---- | ---- | ---- | ---- | ---- |
Operating income | -7.79%37.09B | -8.39%24.68B | -9.34%16.67B | 8.10%7.5B | 4.85%40.22B | 6.36%26.94B | 2.90%18.38B | 5.62%6.94B | -4.40%38.36B | 5.89%25.33B |
Operating expenses | 10.46%-27.47B | 11.74%-18.39B | 11.60%-12.48B | -9.83%-5.79B | -2.79%-30.68B | -7.39%-20.83B | -2.76%-14.12B | -9.17%-5.27B | 4.55%-29.85B | -7.21%-19.4B |
Gross profit | 0.80%9.62B | 3.03%6.3B | -1.85%4.18B | 2.61%1.71B | 12.07%9.54B | 2.97%6.11B | 3.37%4.26B | -4.24%1.67B | -3.88%8.51B | 1.82%5.93B |
Selling expenses | -9.96%-893.03M | -8.29%-553.72M | -10.22%-343.04M | -5.16%-170.43M | -1.93%-812.11M | 8.68%-511.33M | 13.93%-311.24M | 9.03%-162.06M | -1.80%-796.77M | -14.52%-559.92M |
Administrative expenses | -2.00%-2.34B | 1.91%-1.46B | -1.55%-970.23M | -5.27%-463.26M | -8.17%-2.29B | -0.14%-1.49B | 2.71%-955.4M | 17.36%-440.06M | -2.79%-2.12B | -8.91%-1.48B |
Research and development expenses | -10.21%-1.86B | -0.53%-1.09B | -0.02%-648.67M | -6.14%-305.95M | -3.13%-1.69B | -10.54%-1.08B | -0.80%-648.57M | 6.97%-288.26M | -14.24%-1.64B | -17.73%-977.81M |
Profit from asset sales | -99.78%63.7K | -99.56%131.66K | -99.14%230.7K | 70.12%-37.4K | -17.66%29.6M | 12.05%29.66M | 5.86%26.78M | -102.20%-125.16K | -79.00%35.95M | 1.96%26.47M |
Impairment and provision | 17.15%-461.56M | 30.67%-94.83M | 31.04%-75.42M | 163.87%26.6M | -114.10%-557.14M | -153.53%-136.78M | -87.37%-109.37M | -414.70%-41.65M | -771.24%-260.23M | -80.05%-53.95M |
-Other impairment is provision | 17.15%-461.56M | 30.67%-94.83M | 31.04%-75.42M | 163.87%26.6M | -114.10%-557.14M | -153.53%-136.78M | -87.37%-109.37M | -414.70%-41.65M | -771.24%-260.23M | -80.05%-53.95M |
Operating interest expense | ---732.17K | ---482.39K | ---144.56K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | 13.75%555.59M | -4.04%380.75M | -6.79%298.49M | -21.70%121.19M | 8.34%488.42M | 94.97%396.78M | 125.10%320.23M | 394.85%154.77M | 63.98%450.8M | 7.57%203.51M |
Operating profit | -2.37%4.36B | 5.04%3.33B | -5.40%2.34B | 4.52%879.24M | 13.59%4.47B | 8.01%3.17B | 15.38%2.47B | 16.08%841.2M | -17.48%3.93B | -7.72%2.94B |
Financing cost | 26.15%300.23M | -39.03%201.2M | -23.68%143.31M | 37.26%56.62M | -23.82%237.98M | 34.40%330M | -8.30%187.78M | -40.36%41.25M | 25.12%312.38M | -4.68%245.53M |
Special items of earning before tax | -23.33%29.44M | -44.65%14.14M | -2.46%10.1M | 24.92%4.54M | 30.11%38.4M | 11.53%25.54M | -60.60%10.36M | -45.35%3.64M | 39.42%29.52M | 64.95%22.9M |
Earning before tax | -1.11%4.69B | 0.55%3.55B | -6.67%2.49B | 6.13%940.4M | 10.97%4.74B | 10.06%3.53B | 12.49%2.67B | 10.69%886.08M | -15.13%4.27B | -7.20%3.2B |
Tax | -5.20%-675.45M | -2.88%-594.43M | 19.71%-383.19M | -11.29%-163.74M | -10.51%-642.05M | -8.34%-577.78M | -41.78%-477.27M | -8.64%-147.12M | 27.05%-581M | 0.79%-533.28M |
After-tax profit from continuing operations | -2.09%4.01B | 0.10%2.95B | -3.83%2.11B | 5.10%776.66M | 11.04%4.1B | 10.40%2.95B | 7.65%2.19B | 11.11%738.95M | -12.89%3.69B | -8.38%2.67B |
Earning after tax | -2.09%4.01B | 0.10%2.95B | -3.83%2.11B | 5.10%776.66M | 11.04%4.1B | 10.40%2.95B | 7.65%2.19B | 11.11%738.95M | -12.89%3.69B | -8.38%2.67B |
Minority profit | 15.10%537.51M | 10.95%385.08M | 10.15%284.74M | 8.53%98.69M | 11.66%467M | 32.81%347.06M | 31.73%258.51M | 15.39%90.94M | -0.51%418.24M | -0.49%261.32M |
Profit attributable to shareholders | -4.30%3.48B | -1.35%2.57B | -5.70%1.82B | 4.62%677.96M | 10.96%3.63B | 7.97%2.6B | 5.08%1.93B | 10.54%648.02M | -14.25%3.27B | -9.16%2.41B |
Basic earnings per share | -3.03%0.32 | -4.00%0.24 | -5.56%0.17 | 0.00%0.06 | 10.00%0.33 | 13.64%0.25 | 12.50%0.18 | 0.00%0.06 | -11.76%0.3 | -8.33%0.22 |
Diluted earnings per share | -3.03%0.32 | -4.00%0.24 | -5.56%0.17 | 0.00%0.06 | 10.00%0.33 | 13.64%0.25 | 12.50%0.18 | 0.00%0.06 | -11.76%0.3 | -8.33%0.22 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Lixin Certified Public Accountants (special general partnership) | -- | -- | -- | Lixin Certified Public Accountants (special general partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data